Showing results (151-160 of 189) with videos related to
Sort By:
Pageof 19
ESC Heart Failure|November 6, 2024
Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational studyRichard J Nies, Svenja Ney, Ingrid Kindermann, et al.Journal of the American College of Cardiology|November 17, 2024
Treating Older Patients in Cardiogenic Shock With a Microaxial Flow Pump: Is it DANGERous?Anika Klein, Rasmus P Beske, Christian Hassager, et al.Ebiomedicine|November 12, 2025
Impaired mitochondrial ketone body oxidation in insulin resistant statesElric Zweck, Sarah Piel, Johannes W Schmidt, et al.Circulation|October 27, 2024
Microaxial Flow Pump Use and Renal Outcomes in Infarct-Related Cardiogenic Shock: A Secondary Analysis of the DanGer Shock TrialElric Zweck, Christian Hassager, Rasmus P Beske, et al.Lancet (London, England)|September 5, 2024
Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-upHolger Thiele, Jacob E Møller, Jose P S Henriques, et al.The Journal of Invasive Cardiology|October 13, 2022
A Novel Model to Predict 1-Year Mortality in Elective Transfemoral Aortic Valve Replacement: The TAVR-Risk ScoreChristian Jung, Buntaro Fujita, Kari Feldt, et al.Journal of Cardiac Failure|March 5, 2026
Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock - a Secondary Analysis of the DanGer Shock TrialElric Zweck, Rasmus P Beske, Christian Hassager, et al.International Journal of Cardiology|December 31, 2023
Heparin dosing in patients with Impella-supported cardiogenic shockChristophe Vandenbriele, René M'Pembele, Lisa Dannenberg, et al.Circulation. Cardiovascular Interventions|January 12, 2026
Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock TrialLisette Okkels Jensen, Rasmus Paulin Beske, Hans Eiskjær, et al.JAMA Cardiology|August 30, 2025
Systolic Blood Pressure and Microaxial Flow Pump-Associated Survival in Infarct-Related Cardiogenic Shock: A Post Hoc Analysis of the DanGer Shock Randomized Clinical TrialAstrid Duus Mikkelsen, Rasmus Paulin Beske, Lisette Okkels Jensen, et al.Pageof 19